FDA 483 - Oximeter Plus, Inc - July 21, 2023

An FDA inspection of Oximeter Plus, Inc. in Roslyn Heights, NY, an initial importer and distributor, revealed a significant quality system deficiency. The firm failed to establish adequate procedures for controlling non-conforming products and documenting receiving inspections. Specifically, the company did not document receiving inspections for incoming oximeters.